DSFRX
Price
$39.58
Change
-$0.21 (-0.53%)
Updated
Sep 5 closing price
Net Assets
1.14B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

DSFRX vs RGEBX

Header iconDSFRX vs RGEBX Comparison
Open Charts DSFRX vs RGEBXBanner chart's image
Domini Impact Equity Y
Price$39.58
Change-$0.21 (-0.53%)
VolumeN/A
Net Assets1.14B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
DSFRX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DSFRX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSFRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. DSFRX (1.14B). DSFRX pays higher dividends than RGEBX: DSFRX (0.54) vs RGEBX (0.00). DSFRX was incepted earlier than RGEBX: DSFRX (22 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than DSFRX (0.97). RGEBX is a more actively managed with annual turnover of: 25.00 vs. DSFRX (9.00). DSFRX has a lower initial minimum investment than RGEBX: DSFRX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. DSFRX (8.92). DSFRX return over 5 years is better than : 46.61 vs. RGEBX (38.71).
DSFRXRGEBXDSFRX / RGEBX
Total Expense Ratio0.801.0973%
Annual Report Gross Expense Ratio0.971.0989%
Fund Existence22 years11 years-
Gain YTD6.65215.39843%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B332B0%
Annual Yield % from dividends0.540.00-
Returns for 1 year8.9217.5951%
Returns for 3 years50.6457.6188%
Returns for 5 years46.6138.71120%
Returns for 10 years-9.5791.44-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
METC28.183.20
+12.81%
Ramaco Resources
ROIV12.920.35
+2.78%
Roivant Sciences Ltd
ATMVU12.71N/A
N/A
AlphaVest Acquisition Corp
AIRS5.88-0.02
-0.34%
AirSculpt Technologies
CTSO0.97-0.01
-1.01%
Cytosorbents Corp